Overview

• At the Wells Fargo Healthcare Conference, Oscar Health reiterated full‑year 2025 revenue of $12.0 billion to $12.2 billion, topping the $11.32 billion consensus.
• The stock jumped 7.61% to $17.68 on Wednesday and traded up another 3.70% to $18.34 Thursday morning as gains carried over.
• Second‑quarter revenue rose to $2.86 billion from $2.2 billion year over year on higher membership, though the company reported a GAAP loss of $0.89 per share.
• Management projected a 2025 medical loss ratio of 86% to 87%, highlighting continued pressure on underwriting margins.
• Oscar also highlighted a new partnership with Hy‑Vee to offer an employer health plan in Des Moines, Iowa, as it pursues growth initiatives.